Origin Life Sciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 5

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 1

Origin Life Sciences General Information

Description

Origin Life Sciences Inc is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates NO in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream potentially can be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and SSTIs. The cornerstone of the plasma/NO therapy is its patented delivery platform named IonoJet which allows it to turn atmospheric air into a plasma/NO stream.

Contact Information

Formerly Known As
Advanced Plasma Therapies, Advanced Plasma Therapies Incorporated, Advanced Plasma Therapies, Inc., Plasma Jet Technologies
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Two Research Way
  • Third Floor
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Two Research Way
  • Third Floor
  • Princeton, NJ 08540
  • United States
+1 (609)

Origin Life Sciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Origin Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 13-Mar-2023 $7.5M Announced Generating Revenue/Not Profitable
7. Later Stage VC 17-Oct-2023 Completed Generating Revenue/Not Profitable
6. Later Stage VC 07-Sep-2022 Completed Clinical Trials - Phase 3
5. Later Stage VC 15-Jun-2021 Completed Clinical Trials - Phase 3
4. Secondary Transaction - Private 04-Sep-2019 Completed Clinical Trials - Phase 3
3. Later Stage VC 11-May-2017 Completed Startup
2. Early Stage VC 21-Nov-2014 $28.2M $28.7M Completed Startup
1. Early Stage VC 04-Apr-2013 $500K $500K Completed Startup
To view Origin Life Sciences’s complete valuation and funding history, request access »

Origin Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Origin Life Sciences Inc is a clinical-stage biotechnology company that has been developing a proprietary patented high-
Other Devices and Supplies
Princeton, NJ
5 As of 2024

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Origin Life Sciences Competitors (1)

One of Origin Life Sciences’s competitors is SaNOtize, a Venture Capital-Backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SaNOtize Venture Capital-Backed Vancouver, Canada
You’re viewing 1 of 1 competitors. Get the full list »

Origin Life Sciences Patents

Origin Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240277757-A1 Methods of using a plasma-generated stream of no-containing gas for treatment of a spectrum of medical conditions Pending 17-Jun-2021
EP-4126154-A1 System and method for treatment using nitric oxide Pending 23-Mar-2020
CA-3174415-A1 System and method for treatment using nitric oxide Pending 23-Mar-2020
US-20230133668-A1 System and method for treatment with nitric oxide Pending 23-Mar-2020
EP-4126154-A4 System and method for treatment using nitric oxide Pending 23-Mar-2020 A61M16/125
To view Origin Life Sciences’s complete patent history, request access »

Origin Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Origin Life Sciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Woodford Investment Management Asset Manager Minority
To view Origin Life Sciences’s complete investors history, request access »

Origin Life Sciences FAQs

  • When was Origin Life Sciences founded?

    Origin Life Sciences was founded in 2010.

  • Where is Origin Life Sciences headquartered?

    Origin Life Sciences is headquartered in Princeton, NJ.

  • What is the size of Origin Life Sciences?

    Origin Life Sciences has 5 total employees.

  • What industry is Origin Life Sciences in?

    Origin Life Sciences’s primary industry is Other Devices and Supplies.

  • Is Origin Life Sciences a private or public company?

    Origin Life Sciences is a Private company.

  • What is the current valuation of Origin Life Sciences?

    The current valuation of Origin Life Sciences is .

  • What is Origin Life Sciences’s current revenue?

    The current revenue for Origin Life Sciences is .

  • How much funding has Origin Life Sciences raised over time?

    Origin Life Sciences has raised $47.2M.

  • Who are Origin Life Sciences’s investors?

    Woodford Investment Management has invested in Origin Life Sciences.

  • Who are Origin Life Sciences’s competitors?

    SaNOtize is a competitor of Origin Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »